Dangos
1 - 3
canlyniadau o
3
Neidio i'r cynnwys
Mewngofnodi
Iaith
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
Māori
Pob Maes
Teitl
Awdur
Pwnc
Rhif Galw
ISBN/ISSN
Tag
Canfod
Uwch
Awdur
Benjamin Wuest
Canlyniadau Chwilio - Benjamin Wuest
Dangos
1 - 3
canlyniadau o
3
Mireinio'r Canlyniadau
Sortio
Perthnasedd
Dyddiad Trefn Ddisgynnol
Dyddiad Trefn Esgynnol
Rhif Galw
Awdur
Teitl
1
Systematic Review of Safety and Efficacy of Second- and Third-Generation CD20-Targeting Biologics in Treating Immune-Mediated Disorders
gan
Celine Kaegi
,
Benjamin Wuest
,
Catherine Crowley
,
Onur Boyman
Cyhoeddwyd 2022
Cael y testun llawn
Cael y testun llawn
Revisão
Ychwanegu at ffefrynnau
Wedi'i Gadw mewn:
2
Systematic Review of Safety and Efficacy of Atacicept in Treating Immune-Mediated Disorders
gan
Celine Kaegi
,
Urs C. Steiner
,
Benjamin Wuest
,
Catherine Crowley
,
Onur Boyman
Cyhoeddwyd 2020
Cael y testun llawn
Cael y testun llawn
Artigo
Ychwanegu at ffefrynnau
Wedi'i Gadw mewn:
3
Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
gan
Celine Kaegi
,
Benjamin Wuest
,
Jens Schreiner
,
Urs C. Steiner
,
Alessandra Vultaggio
,
Andrea Matucci
,
Catherine Crowley
,
Onur Boyman
Cyhoeddwyd 2019
Cael y testun llawn
Cael y testun llawn
Revisão
Ychwanegu at ffefrynnau
Wedi'i Gadw mewn:
Offerynnau Chwilio:
Cael Porthiant RSS
E-bostio'r Chwiliad hwn
Pynciau Perthynol
Antibody
Immunology
Medicine
Etanercept
Internal medicine
Rheumatoid arthritis
Rituximab
Adverse effect
B cell
B-cell activating factor
Belimumab
CD20
Clinical trial
Dermatology
Immune system
Obinutuzumab
Ocrelizumab
Ofatumumab
Oncology
Please ensure Javascript is enabled for purposes of
website accessibility